We’re delighted to announce the launch of the Sandwich Economic Impact Report, which outlines the economic and social footprint of our Sandwich site.
 | The impact of Pfizer's Sandwich site in the UK |
Commissioned by Pfizer and produced by consultancy firm Public First, the report demonstrates that Pfizer and our Sandwich site remain a significant contributor to the overall prosperity and wellbeing of not just the local area but beyond to wider Kent and the whole of the UK.
The key findings are:
Pfizer’s Sandwich site plays a crucial role in the development of life-saving medicines
- Since 2014 the company has spent over £1.2 billion supporting UK R&D (primarily at Sandwich) and around 85% of all Pfizer’s small molecule products pass through the site on their journey to market.
Pfizer Sandwich impacts millions of patients globally
- The site contributes to ensuring millions of patients in over 100 countries continue to receive our medicines through our licence maintenance activities
The site is a key anchor employer for the local area, boosting its economy and culture
- We’ve estimated that for every Pfizer job at Sandwich, an additional two are created or supported across the economy – 2,378 jobs in total – and that colleagues at the site contribute around £10 million a year to the Kent economy through spending with local businesses and charities.
Colleagues at the site are highly productive and are overwhelmingly proud of their work
- The 754 colleagues in Sandwich generate an estimated £267 million in gross added value (GVA) for the UK economy – far above the UK average – and, of those answering our colleague survey at the site, 96% agreed with the statement that they were proud to work for Pfizer at Sandwich and 83% thought that the things they did in their job were highly worthwhile.
Sandwich is helping to train and encourage the next generation of scientists
- The site has around 30 graduate placements and 10 apprenticeships at any one time and in 2018-19 around 17,000 students and school children were involved in programmes run directly by Pfizer colleagues in the region, such as Community Lab and Lab in a Box.
PP-PFE-GBR-4217 / November 2021
